Chronic pain is classified as pain that lasts longer than three months. In medicine, the distinction between acute and chronic pain is sometimes determined by the amount of time since onset. Two commonly used markers are pain that continues at three months and six months since onset, but some theorists and researchers have placed the transition from acute to chronic pain at twelve months. Others apply the term acute to pain that lasts less than 30 days, chronic to pain of more than six months duration, and subacute to pain that lasts from one to six months. A popular alternative definition of chronic pain, involving no fixed duration, is "pain that extends beyond the expected period of healing".
Chronic pain may originate in the body, or in the brain or spinal cord. It is often difficult to treat. Epidemiological studies have found that 8–11.2% of people in various countries have chronic widespread pain. Various non-opioid medicines are initially recommended to treat chronic pain, depending on whether the pain is due to tissue damage or is neuropathic. Psychological treatments including cognitive behavioral therapy and acceptance and commitment therapy may be effective for improving quality of life in those with chronic pain. Some people with chronic pain may benefit from opioid treatment while others can be harmed by it. People with non-cancer pain who have not been helped by non-opioid medicines might be recommended to try opioids if there is no history of substance use disorder and no current mental illness.
People with chronic pain tend to have higher rates of depression and although the exact connection between the comorbidities is unclear, a 2017 study on neuroplasticity found that "injury sensory pathways of body pains have been shown to share the same brain regions involved in mood management." Chronic pain can contribute to decreased physical activity due to fear of making the pain worse. Pain intensity, pain control, and resilience to pain can be influenced by different levels and types of social support that a person with chronic pain receives, and are also influenced by the person's socioeconomic status.
One approach to predicting a person's experience of chronic pain is the biopsychosocial model, according to which an individual's experience of chronic pain may be affected by a complex mixture of their biology, psychology, and their social environment.
The International Association for the Study of Pain defines chronic pain as pain with no biological value, that persists past normal tissue healing. The DSM-5 recognizes one chronic pain disorder, somatic symptom disorders. The criteria include pain lasting longer than six months.
The International Classification of Disease, Eleventh Revision (ICD-11) suggests seven categories for chronic pain.
- Chronic primary pain: defined by 3 months of persistent pain in one or more regions of the body that is unexplainable by another pain condition.
- Chronic cancer pain: defined as cancer or treatment related visceral (within the internal organs), musculoskeletal, or bony pain.
- Chronic post-traumatic pain: pain lasting 3 months after an injury or surgery, excluding infectious or pre-existing conditions.
- Chronic neuropathic pain: pain caused by damage to the somatosensory nervous system.
- Chronic headache and orofacial pain: pain that originates in the head or face, and occurs for 50% or more days over a 3 months period.
- Chronic visceral pain: pain originating in an internal organ.
- Chronic musculoskeletal pain: pain originating in the bones, muscles, joints or connective tissue.
Chronic pain may be divided into "nociceptive" (caused by inflamed or damaged tissue activating specialized pain sensors called nociceptors), and "neuropathic" (caused by damage to or malfunction of the nervous system).
Nociceptive pain can be divided into "superficial" and "deep", and deep pain into "deep somatic" and "visceral". Superficial pain is initiated by activation of nociceptors in the skin or superficial tissues. Deep somatic pain is initiated by stimulation of nociceptors in ligaments, tendons, bones, blood vessels, fasciae and muscles, and is dull, aching, poorly-localized pain. Visceral pain originates in the viscera (organs). Visceral pain may be well-localized, but often it is extremely difficult to locate, and several visceral regions produce "referred" pain when damaged or inflamed, where the sensation is located in an area distant from the site of pathology or injury.
Neuropathic pain is divided into "peripheral" (originating in the peripheral nervous system) and "central" (originating in the brain or spinal cord). Peripheral neuropathic pain is often described as "burning", "tingling", "electrical", "stabbing", or "pins and needles".
Under persistent activation, the transmission of pain signals to the dorsal horn may produce a pain wind-up phenomenon. This triggers changes that lower the threshold for pain signals to be transmitted. In addition, it may cause nonnociceptive nerve fibers to respond to, generate, and transmit pain signals. The type of nerve fibers that are believed to generate the pain signals are the C-fibers, since they have a slow conductivity and give rise to a painful sensation that persists over a long time. In chronic pain, this process is difficult to reverse or stop once established. In some cases, chronic pain can be caused by genetic factors which interfere with neuronal differentiation, leading to a permanently lowered threshold for pain.
Chronic pain of different causes has been characterized as a disease that affects brain structure and function. MRI studies have shown abnormal anatomical and functional connectivity, even during rest involving areas related to the processing of pain. Also, persistent pain has been shown to cause grey matter loss, which is reversible once the pain has resolved.
These structural changes can be explained by neuroplasticity. In the case of chronic pain, the somatotopic representation of the body is inappropriately reorganized following peripheral and central sensitization. This can cause allodynia or hyperalgesia. In individuals with chronic pain, EEGs showed altered brain activity, suggesting pain-induced neuroplastic changes. More specifically, the relative beta activity (compared to the rest of the brain) was increased, the relative alpha activity was decreased, and the theta activity was diminished.
Dysfunctional dopamine management in the brain could potentially act as a shared mechanism between chronic pain, insomnia and major depressive disorder. Astrocytes, microglia, and satellite glial cells have also been found to be dysfunctional in chronic pain. Increased activity of microglia, alterations of microglial networks, and increased production of chemokines and cytokines by microglia might aggravate chronic pain. Astrocytes have been observed to lose their ability to regulate the excitability of neurons, increasing spontaneous neural activity in pain circuits.
Pain management is a branch of medicine that uses an interdisciplinary approach. The combined knowledge of various medical professions and allied health professions is used to ease pain and improve the quality of life of those living with pain. The typical pain management team includes medical practitioners (particularly anesthesiologists), rehabilitation psychologists, physiotherapists, occupational therapists, physician assistants, and nurse practitioners. Acute pain usually resolves with the efforts of one practitioner; however, the management of chronic pain frequently requires the coordinated efforts of a treatment team. Complete, longterm remission of many types of chronic pain is rare.
Initially recommended efforts are non opioid based therapies. Non-opioid treatment of chronic pain with pharmaceutical medicines might include acetaminophen (paracetamol) or NSAIDs.
Various other nonopioid medicines can be used, depending on whether the pain is a result of tissue damage or is neuropathic (pain caused by a damaged or dysfunctional nervous system). There is limited evidence that cancer pain or chronic pain from tissue damage as a result of a conditions (e.g. rheumatoid arthritis) is best treated with opioids. For neuropathic pain other drugs may be more effective than opioids, such as tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, and anticonvulsants. Some atypical antipsychotics, such as olanzapine, may also be effective, but the evidence to support this is in very early stages. In women with chronic pain, hormonal medications such as oral contraceptive pills ("the pill") might be helpful. When there is no evidence of a single best fit, doctors may need to look for a treatment that works for the individual person. It is difficult for doctors to predict who will use opioids just for pain management and who will go on to develop an addiction. It is also challenging for doctors to know which patients ask for opioids because they are living with an opioid addiction. Withholding, interrupting or withdrawing opioid treatment in people who benefit from it can cause harm.
Interventional pain management may be appropriate, including techniques such as trigger point injections, neurolytic blocks, and radiotherapy. While there is no high quality evidence to support ultrasound, it has been found to have a small effect on improving function in non-specific chronic low back pain.
Psychological treatments, including cognitive behavioral therapy and acceptance and commitment therapy can be helpful for improving quality of life and reducing pain interference. Brief mindfulness-based treatment approaches have been used, but they are not yet recommended as a first-line treatment. The effectiveness of mindfulness-based pain management (MBPM) has been supported by a range of studies.
Among older adults psychological interventions can help reduce pain and improve self-efficacy for pain management. Psychological treatments have also been shown to be effective in children and teens with chronic headache or mixed chronic pain conditions.
While exercise has been offered as a method to lessen chronic pain and there is some evidence of benefit, this evidence is tentative. For people living with chronic pain, exercise results in few side effects.
In those who have not benefited from other measures and have no history of either mental illness or substance use disorder treatment with opioids may be tried. If significant benefit does not occur it is recommended that they be stopped. In those on opioids, stopping or decreasing their use may improve outcomes including pain.
Some people with chronic pain benefit from opioid treatment and others do not; some are harmed by the treatment. Possible harms include reduced sex hormone production, hypogonadism, infertility, impaired immune system, falls and fractures in older adults, neonatal abstinence syndrome, heart problems, sleep-disordered breathing, opioid-induced hyperalgesia, physical dependence, addiction, abuse, and overdose.
Alternative medicine refers to health practices or products that are used to treat pain or illness that are not necessarily considered a part of conventional medicine. When dealing with chronic pain, these practices generally fall into the following four categories: biological, mind-body, manipulative body, and energy medicine.
Implementing dietary changes, which is considered a biological-based alternative medicine practice, has been shown to help improve symptoms of chronic pain over time. Adding supplements to one's diet is a common dietary change when trying to relieve chronic pain, with some of the most studied supplements being: Acetyl-L-carnitine, alpha lipoic acid, and vitamin E. Vitamin E is perhaps the most studied out of the three, with strong evidence that it helps lower neurotoxicity in those with cancer, multiple sclerosis, and cardiovascular diseases.
Hypnosis, including self-hypnosis, has tentative evidence. Hypnosis, specifically, can offer pain relief for most people and may be a safe alternative to pharmaceutical medication. Evidence does not support hypnosis for chronic pain due to a spinal cord injury.
Preliminary studies have found medical marijuana to be beneficial in treating neuropathic pain, but not other kinds of long term pain. As of 2018[update], the evidence for its efficacy in treating neuropathic pain or pain associated with rheumatic diseases is not strong for any benefit and further research is needed. For chronic non-cancer pain, a recent study concluded that it is unlikely that cannabinoids are highly effective. However, more rigorous research into cannabis or cannabis-based medicines is needed.
Tai chi has been shown to improve pain, stiffness, and quality of life in chronic conditions such as osteoarthritis, low back pain, and osteoporosis. Acupuncture has also been found to be an effective and safe treatment in reducing pain and improving quality of life in chronic pain including chronic pelvic pain syndrome.
Transcranial magnetic stimulation for reduction of chronic pain is not supported by high quality evidence, and the demonstrated effects are small and short-term.
Spa therapy could potentially improve pain in patients with chronic lower back pain, but more studies are needed to provide stronger evidence of this.
While some studies have investigated the efficacy of St John's Wort or nutmeg for treating neuropathic (nerve) pain, their findings have raised serious concerns about the accuracy of their results.
Kinesio Tape has not been shown to be effective in managing chronic non-specific low-back pain.
Myofascial release has been used in some cases of fibromyalgia, chronic low back pain, and tennis elbow but there is not enough evidence to support this as method of treatment.
Chronic pain varies in different countries affecting anywhere from 8% to 55% of the population. It affects women at a higher rate than men, and chronic pain uses a large amount of healthcare resources around the globe.
A large-scale telephone survey of 15 European countries and Israel found that 19% of respondents over 18 years of age had suffered pain for more than 6 months, including the last month, and more than twice in the last week, with pain intensity of 5 or more for the last episode, on a scale of 1 (no pain) to 10 (worst imaginable). 4839 of these respondents with chronic pain were interviewed in-depth. Sixty-six percent scored their pain intensity at moderate (5–7), and 34% at severe (8–10); 46% had constant pain, 56% intermittent; 49% had suffered pain for 2–15 years; and 21% had been diagnosed with depression due to the pain. Sixty-one percent were unable or less able to work outside the home, 19% had lost a job, and 13% had changed jobs due to their pain. Forty percent had inadequate pain management and less than 2% were seeing a pain management specialist.
In the United States, chronic pain has been estimated to occur in approximately 35% of the population, with approximately 50 million Americans experiencing partial or total disability as a consequence. According to the Institute of Medicine, there are about 116 million Americans living with chronic pain, which suggests that approximately half of American adults have some chronic pain condition. The Mayday Fund estimate of 70 million Americans with chronic pain is slightly more conservative. In an internet study, the prevalence of chronic pain in the United States was calculated to be 30.7% of the population: 34.3% for women and 26.7% for men.
In Canada it is estimated that approximately 1 in 5 Canadians live with chronic pain and half of those people have lived with chronic pain for 10 years or longer. Chronic pain in Canada also occurs more and is more severe in women and Canada's Indigenous communities.
Sleep disturbance, and insomnia due to medication and illness symptoms are often experienced by those with chronic pain. These conditions can be difficult to treat due to the high potential of medication interactions, especially when the conditions are treated by different doctors.
Severe chronic pain is associated with increased risk of death over a ten-year period, particularly from heart disease and respiratory disease. Several mechanisms have been proposed for this increase, such as an abnormal stress response in the body's endocrine system. Additionally, chronic stress seems to affect risks to heart and lung (cardiovascular) health by increasing how quickly plaque can build up on artery walls (arteriosclerosis). However, further research is needed to clarify the relationship between severe chronic pain, stress and cardiovascular health.
Two of the most frequent personality profiles found in people with chronic pain by the Minnesota Multiphasic Personality Inventory (MMPI) are the conversion V and the neurotic triad. The conversion V personality expresses exaggerated concern over body feelings, develops bodily symptoms in response to stress, and often fails to recognize their own emotional state, including depression. The neurotic triad personality also expresses exaggerated concern over body feelings and develops bodily symptoms in response to stress, but is demanding and complaining.
Some investigators have argued that it is this neuroticism that causes acute pain to turn chronic, but clinical evidence points the other way, to chronic pain causing neuroticism. When long term pain is relieved by therapeutic intervention, scores on the neurotic triad and anxiety fall, often to normal levels. Self-esteem, often low in people with chronic pain, also shows improvement once pain has resolved.
It has been suggested that catastrophizing might play a role in the experience of pain. Pain catastrophizing is the tendency to describe a pain experience in more exaggerated terms than the average person, to think a great deal more about the pain when it occurs, or to feel more helpless about the experience. People who score highly on measures of catastrophization are likely to rate a pain experience as more intense than those who score low on such measures. It is often reasoned that the tendency to catastrophize causes the person to experience the pain as more intense. One suggestion is that catastrophizing influences pain perception through altering attention and anticipation, and heightening emotional responses to pain. However, at least some aspects of catastrophization may be the product of an intense pain experience, rather than its cause. That is, the more intense the pain feels to the person, the more likely they are to have thoughts about it that fit the definition of catastrophization.
Comorbidity with trauma
Individuals with posttraumatic stress disorder (PTSD) have a high comorbidity with chronic pain. Patients with both PTSD and chronic pain report higher severity of pain than those who do not have a PTSD comorbidity.
Effect on cognition
Chronic pain's impact on cognition is an under-researched area, but several tentative conclusions have been published. Most people with chronic pain complain of cognitive impairment, such as forgetfulness, difficulty with attention, and difficulty completing tasks. Objective testing has found that people in chronic pain tend to experience impairment in attention, memory, mental flexibility, verbal ability, speed of response in a cognitive task, and speed in executing structured tasks. A review of studies in 2018 reports a relationship between people in chronic pain and abnormal results in test of memory, attention, and processing speed.
Social and personal impacts
Social support has important consequences for individuals with chronic pain. In particular, pain intensity, pain control, and resiliency to pain have been implicated as outcomes influenced by different levels and types of social support. Much of this research has focused on emotional, instrumental, tangible and informational social support. People with persistent pain conditions tend to rely on their social support as a coping mechanism and therefore have better outcomes when they are a part of larger more supportive social networks. Across a majority of studies investigated, there was a direct significant association between social activities or social support and pain. Higher levels of pain were associated with a decrease in social activities, lower levels of social support, and reduced social functioning.
Evidence exists for unconscious biases and negative stereotyping against racial minorities requesting pain treatment, although clinical decision making was not affected, according to one 2017 review. Minorities may be denied diagnoses for pain and pain medications, and are more likely to go through substance abuse assessment, and are less likely to transfer for pain specialist referral. Preliminary research showed that health providers might have less empathy for black patients and underestimated their pain levels, resulting in treatment delays. Minorities may experience a language barrier, limiting the high level of engagement between the person with pain and health providers for treatment.
Perceptions of injustice
Similar to the damaging effects seen with catastrophizing, perceived injustice is thought to contribute to the severity and duration of chronic pain. Pain-related injustice perception has been conceptualized as a cognitive appraisal reflecting the severity and irreparability of pain- or injury-related loss (e.g., "I just want my life back"), and externalizing blame and unfairness ("I am suffering because of someone else's negligence."). It has been suggested that understanding problems with top down processing/cognitive appraisals can be used to better understand and treat this problem.
Chronic pain and COVID-19
COVID-19 has disrupted the lives of many, leading to major physical, psychological and socioeconomic impacts in the general population. Social distancing practices defining the response to the pandemic alter familiar patterns of social interaction, creating the conditions for what some psychologists are describing as a period of collective grief. Individuals with chronic pain tend to embody an ambiguous status, at times expressing that their type of suffering places them between and outside of conventional medicine. With a large proportion of the global population enduring prolonged periods of social isolation and distress, one study found that people with chronic pain from COVID-19 experienced more empathy towards their suffering during the pandemic.
Effect of chronic pain in the workplace
In the workplace, chronic pain conditions are a significant problem for both the person with the condition and the organization; a problem only expected to increase in many countries due to an aging workforce. In light of this, it may be helpful for organizations to consider the social environment of their workplace, and how it may be working to ease or worsen chronic pain issues for employees. As an example of how the social environment can affect chronic pain, some research has found that high levels of socially prescribed perfectionism (perfectionism induced by external pressure from others, such as a supervisor) can interact with the guilt felt by a person with chronic pain, thereby increasing job tension, and decreasing job satisfaction.
Mobility and road safety impacts
A 2022 systematic review found that chronic pain could increase crash risk among drivers. Chronic pain drivers report experiencing difficulties with safety maneuvers, such as shoulder checking for blind spots, merging with traffic, turning corners, and reversing the vehicle.
- ^ a b Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. (June 2015). "A classification of chronic pain for ICD-11". Pain. 156 (6): 1003–1007. doi:10.1097/j.pain.0000000000000160. PMC 4450869. PMID 25844555.
- ^ a b Turk DC, Okifuji A (2001). "Pain terms and taxonomies". In Loeser D, Butler SH, Chapman JJ, Turk DC (eds.). Bonica's Management of Pain (3rd ed.). Lippincott Williams & Wilkins. pp. 18–25. ISBN 978-0683304626.
- ^ Main CJ, Spanswick CC (2001). Pain management: an interdisciplinary approach. Elsevier. p. 93. ISBN 978-0443056833.
- ^ Thienhaus O, Cole BE (2002). "Classification of pain". In Weiner RS (ed.). Pain management: A practical guide for clinicians (6 ed.). American Academy of Pain Management. ISBN 978-0849309267.
- ^ a b Andrews P, Steultjens M, Riskowski J (January 2018). "Chronic widespread pain prevalence in the general population: A systematic review". European Journal of Pain. 22 (1): 5–18. doi:10.1002/ejp.1090. PMID 28815801.
- ^ a b Tauben D (May 2015). "Nonopioid medications for pain". Physical Medicine and Rehabilitation Clinics of North America. 26 (2): 219–248. doi:10.1016/j.pmr.2015.01.005. PMID 25952062.
- ^ a b Welsch P, Sommer C, Schiltenwolf M, Häuser W (February 2015). "[Opioids in chronic noncancer pain-are opioids superior to nonopioid analgesics? A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids versus nonopioid analgesics of at least four week's duration]". Schmerz (in German). 29 (1): 85–95. doi:10.1007/s00482-014-1436-0. PMID 25376546.
- ^ a b c Reuben DB, Alvanzo AA, Ashikaga T, Bogat GA, Callahan CM, Ruffing V, Steffens DC (February 2015). "National Institutes of Health Pathways to Prevention Workshop: the role of opioids in the treatment of chronic pain". Annals of Internal Medicine. 162 (4): 295–300. doi:10.7326/M14-2775. PMID 25581341.
- ^ Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. (February 2015). "The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop". Annals of Internal Medicine. 162 (4): 276–286. doi:10.7326/M14-2559. PMID 25581257.
- ^ a b c d Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, et al. (May 2017). "Guideline for opioid therapy and chronic noncancer pain". CMAJ. 189 (18): E659–E666. doi:10.1503/cmaj.170363. PMC 5422149. PMID 28483845.
- ^ IsHak WW, Wen RY, Naghdechi L, Vanle B, Dang J, Knosp M, et al. (2018). "Pain and Depression: A Systematic Review". Harvard Review of Psychiatry. 26 (6): 352–363. doi:10.1097/HRP.0000000000000198. PMID 30407234. S2CID 53212649.
- ^ Sheng J, Liu S, Wang Y, Cui R, Zhang X (2017-06-19). "The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain". Neural Plasticity. 2017: 9724371. doi:10.1155/2017/9724371. PMC 5494581. PMID 28706741.
- ^ "Effective Coping of Chronic Pain Varies With Psychosocial Resource Profiles". APA Journals Article Spotlight. American Psychological Association. 2019-09-20. Archived from the original on 2020-06-09. Retrieved 2021-02-15.
- ^ a b c d Hochwarter W, Byrne ZS (2010). "The Interactive Effects of Chronic Pain, Guilt, and Perfectionism on Work Outcomes". Journal of Applied Social Psychology. 40 (1): 76–100. doi:10.1111/j.1559-1816.2009.00564.x.
- ^ Katz J, Rosenbloom BN, Fashler S (April 2015). "Chronic Pain, Psychopathology, and DSM-5 Somatic Symptom Disorder". Canadian Journal of Psychiatry. 60 (4): 160–167. doi:10.1177/070674371506000402. PMC 4459242. PMID 26174215.
- ^ Keay KA, Clement CI, Bandler R (2000). "The neuroanatomy of cardiac nociceptive pathways". In Horst GJ (ed.). The nervous system and the heart. Totowa, New Jersey: Humana Press. p. 304. ISBN 978-0896036932.
- ^ Coda BA, Bonica JJ (2001). "General considerations of acute pain". In Loeser D, Bonica JJ (eds.). Bonica's management of pain (3 ed.). Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0443056833.
- ^ Diagnostic Methods for Neuropathic Pain: A Review of Diagnostic Accuracy Rapid Response Report: Summary with Critical Appraisal. Canadian Agency for Drugs and Technologies in Health. April 2015. PMID 26180859.
- ^ Bogduk N, Merskey H (1994). Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms (second ed.). Seattle: IASP Press. p. 212. ISBN 978-0931092053.
- ^ Paice JA (Jul–Aug 2003). "Mechanisms and management of neuropathic pain in cancer" (PDF). The Journal of Supportive Oncology. 1 (2): 107–120. PMID 15352654. Archived from the original (PDF) on 2010-01-07. Retrieved 2010-05-03.
- ^ Hansson P (1998). Nociceptive and neurogenic pain. Pharmacia & Upjon AB. pp. 52–63.
- ^ Vadivelu N, Sinatra R (October 2005). "Recent advances in elucidating pain mechanisms". Current Opinion in Anesthesiology. 18 (5): 540–7. doi:10.1097/01.aco.0000183109.27297.75. PMID 16534290. S2CID 22012269.
- ^ Rusanescu G, Mao J (October 2014). "Notch3 is necessary for neuronal differentiation and maturation in the adult spinal cord". Journal of Cellular and Molecular Medicine. 18 (10): 2103–16. doi:10.1111/jcmm.12362. PMC 4244024. PMID 25164209.
- ^ Geha PY, Baliki MN, Harden RN, Bauer WR, Parrish TB, Apkarian AV (November 2008). "The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions". Neuron. 60 (4): 570–81. doi:10.1016/j.neuron.2008.08.022. PMC 2637446. PMID 19038215.
- ^ Baliki MN, Geha PY, Apkarian AV, Chialvo DR (February 2008). "Beyond feeling: chronic pain hurts the brain, disrupting the default-mode network dynamics". The Journal of Neuroscience. 28 (6): 1398–403. doi:10.1523/JNEUROSCI.4123-07.2008. PMC 6671589. PMID 18256259.
- ^ Tagliazucchi E, Balenzuela P, Fraiman D, Chialvo DR (November 2010). "Brain resting state is disrupted in chronic back pain patients". Neuroscience Letters. 485 (1): 26–31. doi:10.1016/j.neulet.2010.08.053. PMC 2954131. PMID 20800649.
- ^ May A (July 2008). "Chronic pain may change the structure of the brain". Pain. 137 (1): 7–15. doi:10.1016/j.pain.2008.02.034. PMID 18410991. S2CID 45515001.
- ^ Seminowicz DA, Wideman TH, Naso L, Hatami-Khoroushahi Z, Fallatah S, Ware MA, et al. (May 2011). "Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function". The Journal of Neuroscience. 31 (20): 7540–50. doi:10.1523/JNEUROSCI.5280-10.2011. PMC 6622603. PMID 21593339.
- ^ Jensen MP, Sherlin LH, Hakiman S, Fregni F (2009). "Neuromodulatory approaches for chronic pain management: research findings and clinical implications". Journal of Neurotherapy. 13 (4): 196–213. doi:10.1080/10874200903334371.
- ^ Finan PH, Smith MT (June 2013). "The comorbidity of insomnia, chronic pain, and depression: dopamine as a putative mechanism". Sleep Medicine Reviews. 17 (3): 173–83. doi:10.1016/j.smrv.2012.03.003. PMC 3519938. PMID 22748562.
- ^ Ji RR, Berta T, Nedergaard M (December 2013). "Glia and pain: is chronic pain a gliopathy?". Pain. 154 (Suppl 1): S10–S28. doi:10.1016/j.pain.2013.06.022. PMC 3858488. PMID 23792284.
- ^ Hardy PA (1997). Chronic pain management: the essentials. UK: Greenwich Medical Media. p. 10. ISBN 978-1900151856.
the reduction of suffering and enhanced quality of life .
- ^ Main CJ, Spanswick CC (2000). Pain management: an interdisciplinary approach. Churchill Livingstone. ISBN 978-0443056833.
- ^ Thienhaus O, Cole BE (2002). "The classification of pain". In Weiner RS (ed.). Pain management: A practical guide for clinicians. CRC Press. p. 29. ISBN 978-0849309267.
- ^ Henningsen P, Zipfel S, Herzog W (March 2007). "Management of functional somatic syndromes". Lancet. 369 (9565): 946–55. doi:10.1016/S0140-6736(07)60159-7. PMID 17368156. S2CID 24730085.
- ^ Stanos S, Houle TT (May 2006). "Multidisciplinary and interdisciplinary management of chronic pain". Physical Medicine and Rehabilitation Clinics of North America. 17 (2): 435–450, vii. doi:10.1016/j.pmr.2005.12.004. PMID 16616276.
- ^ Chou R, Huffman LH (October 2007). "Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline". Annals of Internal Medicine. 147 (7): 505–514. doi:10.7326/0003-4819-147-7-200710020-00008. PMID 17909211.
- ^ "Acetaminophen Monograph for Professionals". Drugs.com. Retrieved 2020-06-30.
- ^ Conaghan PG (June 2012). "A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity". Rheumatology International. 32 (6): 1491–502. doi:10.1007/s00296-011-2263-6. PMC 3364420. PMID 22193214.
- ^ Vardy J, Agar M (June 2014). "Nonopioid drugs in the treatment of cancer pain". Journal of Clinical Oncology. 32 (16): 1677–1690. doi:10.1200/JCO.2013.52.8356. hdl:10453/115544. PMID 24799483.
- ^ Elomrani F, Berrada N, L'annaz S, Ouziane I, Mrabti H, Errihani H (May 2015). "Pain and Cancer: A systematic review". The Gulf Journal of Oncology. 1 (18): 32–37. PMID 26003103.
- ^ a b Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ (July 2015). "Amitriptyline for neuropathic pain in adults". The Cochrane Database of Systematic Reviews. 7 (7): CD008242. doi:10.1002/14651858.CD008242.pub3. PMC 6447238. PMID 26146793.
- ^ a b Gilron I, Baron R, Jensen T (April 2015). "Neuropathic pain: principles of diagnosis and treatment". Mayo Clinic Proceedings. 90 (4): 532–545. doi:10.1016/j.mayocp.2015.01.018. PMID 25841257.
- ^ Jimenez XF, Sundararajan T, Covington EC (June 2018). "A Systematic Review of Atypical Antipsychotics in Chronic Pain Management: Olanzapine Demonstrates Potential in Central Sensitization, Fibromyalgia, and Headache/Migraine". The Clinical Journal of Pain. 34 (6): 585–591. doi:10.1097/AJP.0000000000000567. PMID 29077621. S2CID 699847.
- ^ Carey ET, Till SR, As-Sanie S (March 2017). "Pharmacological Management of Chronic Pelvic Pain in Women". Drugs. 77 (3): 285–301. doi:10.1007/s40265-016-0687-8. PMID 28074359. S2CID 35809874.
- ^ Ebadi S, Henschke N, Forogh B, Nakhostin Ansari N, van Tulder MW, Babaei-Ghazani A, Fallah E (July 2020). "Therapeutic ultrasound for chronic low back pain". The Cochrane Database of Systematic Reviews. 2020 (7): CD009169. doi:10.1002/14651858.CD009169.pub3. PMC 7390505. PMID 32623724.
- ^ Sveinsdottir V, Eriksen HR, Reme SE (2012). "Assessing the role of cognitive behavioral therapy in the management of chronic nonspecific back pain". Journal of Pain Research. 5: 371–380. doi:10.2147/JPR.S25330. PMC 3474159. PMID 23091394.
- ^ Castro MM, Daltro C, Kraychete DC, Lopes J (November 2012). "The cognitive behavioral therapy causes an improvement in quality of life in patients with chronic musculoskeletal pain". Arquivos de Neuro-Psiquiatria. 70 (11): 864–868. doi:10.1590/s0004-282x2012001100008. PMID 23175199.
- ^ Wicksell RK, Kemani M, Jensen K, Kosek E, Kadetoff D, Sorjonen K, et al. (April 2013). "Acceptance and commitment therapy for fibromyalgia: a randomized controlled trial". European Journal of Pain. 17 (4): 599–611. doi:10.1002/j.1532-2149.2012.00224.x. hdl:10616/44579. PMID 23090719. S2CID 32151525.
- ^ Veehof MM, Trompetter HR, Bohlmeijer ET, Schreurs KM (2016). "Acceptance- and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review". Cognitive Behaviour Therapy. 45 (1): 5–31. doi:10.1080/16506073.2015.1098724. PMID 26818413.
- ^ McClintock AS, McCarrick SM, Garland EL, Zeidan F, Zgierska AE (March 2019). "Brief Mindfulness-Based Interventions for Acute and Chronic Pain: A Systematic Review". Journal of Alternative and Complementary Medicine. 25 (3): 265–278. doi:10.1089/acm.2018.0351. PMC 6437625. PMID 30523705.
- ^ Mehan S, Morris J (2018). "A literature review of Breathworks and mindfulness intervention". British Journal of Healthcare Management. 24 (5): 235–241. doi:10.12968/bjhc.2018.24.5.235. ISSN 1358-0574.
- ^ Long J, Briggs M, Long A, Astin F (October 2016). "Starting where I am: a grounded theory exploration of mindfulness as a facilitator of transition in living with a long-term condition" (PDF). Journal of Advanced Nursing. 72 (10): 2445–2456. doi:10.1111/jan.12998. PMID 27174075. S2CID 4917280.
- ^ Brown CA, Jones AK (March 2013). "Psychobiological correlates of improved mental health in patients with musculoskeletal pain after a mindfulness-based pain management program". The Clinical Journal of Pain. 29 (3): 233–244. doi:10.1097/AJP.0b013e31824c5d9f. PMID 22874090. S2CID 33688569.
- ^ Niknejad B, Bolier R, Henderson CR, Delgado D, Kozlov E, Löckenhoff CE, Reid MC (June 2018). "Association Between Psychological Interventions and Chronic Pain Outcomes in Older Adults: A Systematic Review and Meta-analysis". JAMA Internal Medicine. 178 (6): 830–839. doi:10.1001/jamainternmed.2018.0756. PMC 6145761. PMID 29801109.
- ^ Fisher E, Law E, Dudeney J, Palermo TM, Stewart G, Eccleston C, et al. (Cochrane Pain, Palliative and Supportive Care Group) (September 2018). "Psychological therapies for the management of chronic and recurrent pain in children and adolescents". The Cochrane Database of Systematic Reviews. 9 (9): CD003968. doi:10.1002/14651858.CD003968.pub5. PMC 6257251. PMID 30270423.
- ^ a b Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH (April 2017). "Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews". The Cochrane Database of Systematic Reviews. 4 (2): CD011279. doi:10.1002/14651858.CD011279.pub3. PMC 5461882. PMID 28436583.
- ^ Frank JW, Lovejoy TI, Becker WC, Morasco BJ, Koenig CJ, Hoffecker L, et al. (August 2017). "Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review". Annals of Internal Medicine. 167 (3): 181–191. doi:10.7326/m17-0598. PMID 28715848.
- ^ Franklin GM (September 2014). "Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology". Neurology. 83 (14): 1277–1284. doi:10.1212/wnl.0000000000000839. PMID 25267983.
- ^ Higgins C, Smith BH, Matthews K (June 2018). "Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis". British Journal of Anaesthesia. 120 (6): 1335–1344. doi:10.1016/j.bja.2018.03.009. PMID 29793599.
- ^ a b c d Lee FH, Raja SN (January 2011). "Complementary and alternative medicine in chronic pain". Pain. 152 (1): 28–30. doi:10.1016/j.pain.2010.09.023. PMID 20933330. S2CID 6632695.
- ^ Gupta A (2019-10-15). "What are the benefits and harms of acetyl-L-carnitine for treatment of diabetic peripheral neuropathy (DPN)?". Cochrane Clinical Answers. doi:10.1002/cca.2721. ISSN 2050-4217. S2CID 208452418.
- ^ Ziegler D (November 2009). "Painful diabetic neuropathy: advantage of novel drugs over old drugs?". Diabetes Care. 32 (suppl_2): S414–419. doi:10.2337/dc09-s350. PMC 2811478. PMID 19875591.
- ^ a b Argyriou AA, Chroni E, Koutras A, Iconomou G, Papapetropoulos S, Polychronopoulos P, Kalofonos HP (September 2006). "Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation". Journal of Pain and Symptom Management. 32 (3): 237–244. doi:10.1016/j.jpainsymman.2006.03.013. PMID 16939848.
- ^ Elkins G, Johnson A, Fisher W (April 2012). "Cognitive hypnotherapy for pain management". The American Journal of Clinical Hypnosis. 54 (4): 294–310. doi:10.1080/00029157.2011.654284. PMID 22655332. S2CID 40604946.
- ^ Thompson T, Terhune DB, Oram C, Sharangparni J, Rouf R, Solmi M, et al. (April 2019). "The effectiveness of hypnosis for pain relief: A systematic review and meta-analysis of 85 controlled experimental trials" (PDF). Neuroscience and Biobehavioral Reviews. 99: 298–310. doi:10.1016/j.neubiorev.2019.02.013. PMID 30790634. S2CID 72334198.
- ^ Boldt I, Eriks-Hoogland I, Brinkhof MW, de Bie R, Joggi D, von Elm E (November 2014). "Non-pharmacological interventions for chronic pain in people with spinal cord injury". The Cochrane Database of Systematic Reviews. 11 (11): CD009177. doi:10.1002/14651858.CD009177.pub2. PMID 25432061.
- ^ Nugent SM, Morasco BJ, O'Neil ME, Freeman M, Low A, Kondo K, et al. (September 2017). "The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review". Annals of Internal Medicine. 167 (5): 319–331. doi:10.7326/M17-0155. PMID 28806817.
- ^ Ciccone CD (February 2017). "Medical Marijuana: Just the Beginning of a Long, Strange Trip?". Physical Therapy. 97 (2): 239–248. doi:10.2522/ptj.20160367. PMID 27660328.
- ^ " Cannabinoids for Chronic Pain | Therapeutics Initiative". Therapeutics Initiative. 23 November 2018.
- ^ a b Häuser W, Petzke F, Fitzcharles MA (March 2018). "Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews". European Journal of Pain. 22 (3): 455–470. doi:10.1002/ejp.1118. PMID 29034533. S2CID 3443248.
- ^ Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, et al. (October 2018). "Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: a systematic review and meta-analysis of controlled and observational studies". Pain. 159 (10): 1932–1954. doi:10.1097/j.pain.0000000000001293. PMID 29847469. S2CID 44165877.
- ^ Chen YW, Hunt MA, Campbell KL, Peill K, Reid WD (April 2016). "The effect of Tai Chi on four chronic conditions-cancer, osteoarthritis, heart failure and chronic obstructive pulmonary disease: a systematic review and meta-analyses". British Journal of Sports Medicine. 50 (7): 397–407. doi:10.1136/bjsports-2014-094388. PMID 26383108.
- ^ Kong LJ, Lauche R, Klose P, Bu JH, Yang XC, Guo CQ, et al. (April 2016). "Tai Chi for Chronic Pain Conditions: A Systematic Review and Meta-analysis of Randomized Controlled Trials". Scientific Reports. 6: 25325. Bibcode:2016NatSR...625325K. doi:10.1038/srep25325. PMC 4850460. PMID 27125299.
- ^ Vickers AJ, Vertosick EA, Lewith G, MacPherson H, Foster NE, Sherman KJ, et al. (May 2018). "Acupuncture for Chronic Pain: Update of an Individual Patient Data Meta-Analysis". The Journal of Pain. 19 (5): 455–474. doi:10.1016/j.jpain.2017.11.005. PMC 5927830. PMID 29198932.
- ^ Liu BP, Wang YT, Chen SD (December 2016). "Effect of acupuncture on clinical symptoms and laboratory indicators for chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis". International Urology and Nephrology. 48 (12): 1977–1991. doi:10.1007/s11255-016-1403-z. PMID 27590134. S2CID 12344832.
- ^ O'Connell NE, Marston L, Spencer S, DeSouza LH, Wand BM (April 2018). "Non-invasive brain stimulation techniques for chronic pain". The Cochrane Database of Systematic Reviews. 4 (8): CD008208. doi:10.1002/14651858.CD008208.pub5. PMC 6494527. PMID 29652088.
- ^ Bai R, Li C, Xiao Y, Sharma M, Zhang F, Zhao Y (September 2019). "Effectiveness of spa therapy for patients with chronic low back pain: An updated systematic review and meta-analysis". Medicine. 98 (37): e17092. doi:10.1097/MD.0000000000017092. PMC 6750337. PMID 31517832.
- ^ Boyd A, Bleakley C, Hurley DA, Gill C, Hannon-Fletcher M, Bell P, McDonough S (April 2019). "Herbal medicinal products or preparations for neuropathic pain". The Cochrane Database of Systematic Reviews. 4 (5): CD010528. doi:10.1002/14651858.CD010528.pub4. PMC 6445324. PMID 30938843.
- ^ Luz Júnior MA, Almeida MO, Santos RS, Civile VT, Costa LO (January 2019). "Effectiveness of Kinesio Taping in Patients With Chronic Nonspecific Low Back Pain: A Systematic Review With Meta-analysis". Spine. 44 (1): 68–78. doi:10.1097/BRS.0000000000002756. PMID 29952880. S2CID 49486200.
- ^ Laimi K, Mäkilä A, Bärlund E, Katajapuu N, Oksanen A, Seikkula V, et al. (April 2018). "Effectiveness of myofascial release in treatment of chronic musculoskeletal pain: a systematic review". Clinical Rehabilitation. 32 (4): 440–450. doi:10.1177/0269215517732820. PMID 28956477. S2CID 206486404.
- ^ Harstall C, Ospina M (June 2003). "How Prevalent Is Chronic Pain?" (PDF). Pain Clinical Updates. International Association for the Study of Pain. XI (2): 1–4. Archived from the original (PDF) on 2017-06-23.
- ^ Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (May 2006). "Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment". European Journal of Pain. 10 (4): 287–333. doi:10.1016/j.ejpain.2005.06.009. PMID 16095934. S2CID 22834242.
- ^ "Chronic Pain Syndrome: Practice Essentials, Etiology, Patient Education". eMedicine. February 18, 2022.
- ^ Debono DJ, Hoeksema LJ, Hobbs RD (August 2013). "Caring for patients with chronic pain: pearls and pitfalls". The Journal of the American Osteopathic Association. 113 (8): 620–627. doi:10.7556/jaoa.2013.023. PMID 23918913.
- ^ Institute of Medicine of the National Academies Report (2011). Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington DC: The National Academies Press.
- ^ A Call to Revolutionize Chronic Pain Care in America: An Opportunity in Health Care Reform. The Mayday Fund. 2009.
- ^ Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH (November 2010). "The prevalence of chronic pain in United States adults: results of an Internet-based survey". The Journal of Pain. 11 (11): 1230–1239. doi:10.1016/j.jpain.2010.07.002. PMID 20797916.
- ^ a b Health Canada (2019-08-08). "Canadian Pain Task Force Report: June 2019". aem. Retrieved 2020-06-30.
- ^ Ferini-Strambi L (2011). "Sleep disorders in multiple sclerosis". Sleep Disorders. Handb Clin Neurol. Handbook of Clinical Neurology. Vol. 99. pp. 1139–1146. doi:10.1016/B978-0-444-52007-4.00025-4. ISBN 978-0444520074. PMID 21056246.
- ^ a b Torrance N, Elliott AM, Lee AJ, Smith BH (April 2010). "Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study". European Journal of Pain. 14 (4): 380–386. doi:10.1016/j.ejpain.2009.07.006. PMID 19726210. S2CID 22222751.
- ^ McBeth J, Chiu YH, Silman AJ, Ray D, Morriss R, Dickens C, et al. (2005). "Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents". Arthritis Research & Therapy. 7 (5): R992–R1000. doi:10.1186/ar1772. PMC 1257426. PMID 16207340.
- ^ Leo R (2007). Clinical manual of pain management in psychiatry. Washington, DC: American Psychiatric Publishing. p. 58. ISBN 978-1585622757.
- ^ Fishbain DA, Cole B, Cutler RB, Lewis J, Rosomoff HL, Rosomoff RS (1 November 2006). "Chronic pain and the measurement of personality: do states influence traits?". Pain Medicine. 7 (6): 509–529. doi:10.1111/j.1526-4637.2006.00239.x. PMID 17112364.
- ^ Jess P, Jess T, Beck H, Bech P (May 1998). "Neuroticism in relation to recovery and persisting pain after laparoscopic cholecystectomy". Scandinavian Journal of Gastroenterology. 33 (5): 550–553. doi:10.1080/00365529850172151. PMID 9648998.
- ^ Jess P, Bech P (1994). "The validity of Eysenck's neuroticism dimension within the Minnesota Multiphasic Personality Inventory in patients with duodenal ulcer. The Hvidovre Ulcer Project Group". Psychotherapy and Psychosomatics. 62 (3–4): 168–175. doi:10.1159/000288919. PMID 7846260.
- ^ a b Melzack R, Wall PD (1996). The Challenge of Pain (2nd ed.). London: Penguin. pp. 31–32. ISBN 0140256709.
- ^ Van Damme S, Crombez G, Bijttebier P, Goubert L, Van Houdenhove B (April 2002). "A confirmatory factor analysis of the Pain Catastrophizing Scale: invariant factor structure across clinical and non-clinical populations". Pain. 96 (3): 319–324. doi:10.1016/S0304-3959(01)00463-8. PMID 11973004. S2CID 19059827.
- ^ Gracely RH, Geisser ME, Giesecke T, Grant MA, Petzke F, Williams DA, Clauw DJ (April 2004). "Pain catastrophizing and neural responses to pain among persons with fibromyalgia". Brain. 127 (Pt 4): 835–843. doi:10.1093/brain/awh098. PMID 14960499.
- ^ Severeijns R, van den Hout MA, Vlaeyen JW (June 2005). "The causal status of pain catastrophizing: an experimental test with healthy participants". European Journal of Pain. 9 (3): 257–265. doi:10.1016/j.ejpain.2004.07.005. PMID 15862475. S2CID 43047540.
- ^ Fishbain DA, Pulikal A, Lewis JE, Gao J (April 2017). "Chronic Pain Types Differ in Their Reported Prevalence of Post–Traumatic Stress Disorder (PTSD) and There Is Consistent Evidence That Chronic Pain Is Associated with PTSD: An Evidence-Based Structured Systematic Review". Pain Medicine. 18 (4): 711–735. doi:10.1093/pm/pnw065. PMID 27188666. S2CID 205291405.
- ^ Morasco BJ, Lovejoy TI, Lu M, Turk DC, Lewis L, Dobscha SK (April 2013). "The relationship between PTSD and chronic pain: mediating role of coping strategies and depression". Pain. 154 (4): 609–616. doi:10.1016/j.pain.2013.01.001. PMC 3609886. PMID 23398939.
- ^ Siqveland J, Ruud T, Hauff E (January 2017). "Post-traumatic stress disorder moderates the relationship between trauma exposure and chronic pain". European Journal of Psychotraumatology. 8 (1): 1375337. doi:10.1080/20008198.2017.1375337. PMC 5632777. PMID 29038680.
- ^ Kreitler S, Niv D (2007). "Cognitive impairment in chronic pain". Pain: Clinical Updates. XV (4): 1–4. Archived from the original (pdf) on 2018-10-30. Retrieved 2019-01-06.
- ^ Higgins DM, Martin AM, Baker DG, Vasterling JJ, Risbrough V (March 2018). "The Relationship Between Chronic Pain and Neurocognitive Function: A Systematic Review". The Clinical Journal of Pain. 34 (3): 262–275. doi:10.1097/AJP.0000000000000536. PMC 5771985. PMID 28719507.
- ^ Molton IR, Terrill AL (2014). "Overview of persistent pain in older adults". The American Psychologist. 69 (2): 197–207. doi:10.1037/a0035794. PMID 24547805.
- ^ Zaza C, Baine N (November 2002). "Cancer pain and psychosocial factors: a critical review of the literature". Journal of Pain and Symptom Management. 24 (5): 526–542. doi:10.1016/s0885-3924(02)00497-9. PMID 12547052.
- ^ a b Dehon E, Weiss N, Jones J, Faulconer W, Hinton E, Sterling S (August 2017). Choo EK (ed.). "A Systematic Review of the Impact of Physician Implicit Racial Bias on Clinical Decision Making". Academic Emergency Medicine. 24 (8): 895–904. doi:10.1111/acem.13214. PMID 28472533. S2CID 32634889.
- ^ a b c Tait RC, Chibnall JT (2014). "Racial/ethnic disparities in the assessment and treatment of pain: psychosocial perspectives". The American Psychologist. 69 (2): 131–141. doi:10.1037/a0035204. PMID 24547799.
- ^ Sullivan MJ, Yakobov E, Scott W, Tait R (1 November 2014). "Perceived Injustice and Adverse Recovery Outcomes". Psychological Injury and Law. 7 (4): 325–334. doi:10.1007/s12207-014-9209-8. S2CID 143450160.
- ^ Sullivan MJ, Adams H, Horan S, Maher D, Boland D, Gross R (September 2008). "The role of perceived injustice in the experience of chronic pain and disability: scale development and validation". Journal of Occupational Rehabilitation. 18 (3): 249–261. doi:10.1007/s10926-008-9140-5. PMID 18536983. S2CID 23897737.
- ^ Bissell DA, Ziadni MS, Sturgeon JA (March 2018). "Perceived injustice in chronic pain: an examination through the lens of predictive processing". Pain Management. 8 (2): 129–138. doi:10.2217/pmt-2017-0051. PMC 6123883. PMID 29451429.
- ^ a b Dassieu L, Pagé MG, Lacasse A, Laflamme M, Perron V, Janelle-Montcalm A, et al. (June 2021). "Chronic pain experience and health inequities during the COVID-19 pandemic in Canada: qualitative findings from the chronic pain & COVID-19 pan-Canadian study". International Journal for Equity in Health. 20 (1): 147. doi:10.1186/s12939-021-01496-1. PMC 8220113. PMID 34162393.
- ^ Weir K (June 2020). "Grieving Life and Loss". Monitor on Psychology. 51 (4).
- ^ Jackson JE (2005). "Stigma, Liminality, and Chronic Pain: Mind-Body Borderlands". American Ethnologist. 32 (3): 332–353. doi:10.1525/ae.2005.32.3.332. ISSN 0094-0496. JSTOR 3805289.
- ^ Vaezipour A, Oviedo-Trespalacios O, Horswill M, Rod JE, Andrews N, Johnston V, Delhomme P (June 2021). "Impact of chronic pain on driving behaviour: a systematic review" (PDF). Pain. Publish Ahead of Print (3): e401–e416. doi:10.1097/j.pain.0000000000002388. PMID 34174040. S2CID 243184631.
- ^ Vaezipour, Atiyeh; Andrews, Nicole; Oviedo-Trespalacios, Oscar; Amershi, Fatima; Horswill, Mark; Johnston, Venerina; Delhomme, Patricia (1 July 2022). "Exploring driving behaviour from the perspectives of individuals with chronic pain and health professionals". Applied Ergonomics. 102: 103755. doi:10.1016/j.apergo.2022.103755. PMID 35381464. S2CID 247931997.
- Dowell D, Haegerich TM, Chou R (April 2016). "CDC Guideline for Prescribing Opioids for Chronic Pain – United States, 2016". JAMA. 315 (15): 1624–1645. doi:10.1001/jama.2016.1464. PMC 6390846. PMID 26977696.
- Chronic Pain Syndromes at Curlie
- Media related to pain at Wikimedia Commons
- International Association for the Study of Pain Archived 2021-05-01 at the Wayback Machine
This article is a direct transclusion of the Wikipedia article and therefore may not meet the same editing standards as LIMSwiki.